![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_tN_3bN-TSr0MLlpw4mGf4IQQEzpnkGYvQ_KuYVKy5D0IVM5ocT4b_BlEeRfPQF3MB_L6wLptUyPKSlpiEZoUBDM0SzTZqTE77IHShXZyMZI4FQHq1s9PBryxmNSEZVBNl3q9hSa7ipmWVfhg=s0-d) | Forward email to a friend. | | | | | | | New Profiled Company - YFRM | | | Valued Subscribers, Welcome New Members, Our favorite Stem Cell company YFRM has been great for our members so far! We have seen huge gains of up to +450% with many intra day opportunities presenting themselves. Just last week the stock hit a new all time high of 0.33, holding solid support on Friday and closing the week "in the green". We are expecting another incredible week from YFRM, and we want to see our members benefit! Once again, the stock appears to be positioned perfectly to become a major winner for our readers! Exciting news from the company combined with extremely bullish technical's could quickly prompt a major price surge! This is what we like to call a near-perfect scenario for investors! We want our readers to be prepared to take advantage of this company’s impressive potential as YFRM has everything that we look for in an alert and more!. Recent events have thrust this company into the spotlight! Many of the chart's leading indicators are suggesting that YFRM is positioning for major price action. When we factor in the company's recent news, we’re looking for an even stronger push in the near term that could send shares of YFRM to much higher levels from here, very likely beyond +1.00! Right now appears to be the perfect time for traders to research this lucrative situation! Don't wait until it's too late! Stem cell research and treatment is a rapidly emerging sector, and plenty of optimism continues to rally around this company. Never before has there been an opportunity in the stem cell market quite like YFRM. There are many companies out there, but the majority are simply doing research. YFRM is performing clinical studies and therapies NOW! In our opinion, YFRM has the potential to make their shareholders very wealthy. Just remember, in light of all the recent positive news, YFRM is positioning itself to be a leader in the Stem Cell sector which is is estimated to grow to more than $64 billion US by 2015. We are committed to covering YFRM for the long term! | | | | DISCLAIMER | | | Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Full disclaimer can be read at: http://www.bullexchange.com/disclaimer PLEASE NOTE WELL: The Bullexchange.com employees are not Registered as an Investment Advisers in any jurisdiction whatsoever. Release of Liability: Through use of this website viewing or using you agree to hold Bullexchange.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. We are engaged in the business of marketing and advertising companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. Bullexchange.com’s sponsored advertisements do not purport to provide an analysis of any company's financial position, operations or prospects and this is not to be construed as a recommendation by Bullexchange.com or an offer or solicitation to buy or sell any security. Neither the owner of Bullexchange.com nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases. It is possible that a viewer's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed in a release or on our website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. To review our complete disclaimer and additional information, please visit Bullexchange.com. Bullexchange.com makes no recommendation that the securities of the companies profiled or discussed in our releases or on our website should be purchased, sold or held by investors. Notice of Compensation Please be advised that Bullexchange.com receives compensation to perform promotional and advertising services for companies mentioned on our website, social media platforms, & our emails by third parties. The Bullexchange.com and or its affiliates have NOT received any compensation to date for investor communications services but expects to receive $100,000 from a third party non affiliate for two months of coverage. Bullexchange.com receives compensation as a production budget for advertising efforts and will retain amounts over and above the cost of production, copy writing services, mailing and other distribution expenses as a fee for our services. Notice of Stock Price Movements and Volatility Viewers of this newsletter should understand that trading activity and stock prices in many if not all cases tend to increase during the advertisement campaigns of the profiled companies and in many if not all cases tend to decrease thereafter. This tends to create above average volatility and price movements in the profiled company during the advertisement campaign that viewers should take into consideration at all times. Campaigns vary in length, and many are for short periods of time, typically less than a week. Notice of Affiliated and Non-Affiliated Newsletters Bullexchange.com regularly shares research with other affiliated newsletters ("Affiliated Newsletters"). It is also possible that other newsletters or profiles have been created by sources we are unaware of. Viewers should take this into consideration when viewing any increased interest in companies mentioned. Because we receive monetary or securities compensation, most often in the form of common stock (hereafter referred to as the "Shares") for our dissemination of publicly disseminated information (the “Information”) regarding various issuers of securities, we disclose our specific compensation herein and in our individual reports of profiled issuers. It is imperative that all readers visit Bullexchange.com’s full disclaimer (http://www.bullexchange.com/disclaimer) for compensations disclosure and carefully review our Disclaimer in its entirety, which contains important information about penny stocks, our operations, the limited nature of the Information and various risks attendant to the companies that we profile, including that: (a ) we receive our compensation in free trading shares, which we will sell immediately upon their receipt as well as during the dissemination of such Information or within hours, days, weeks or months thereafter, or at any time; as a result, our selling activities will cause significant volatility in the Issuer’s stock price and/or significantly depress the Issuer’s stock price; (b) we will buy and sell the Shares in the open market before, during or after the dissemination of the Information or at any time, which will cause significant volatility in the Issuer’s stock price and/or significantly depress or increase the Issuer’s stock price; (c) there is an inherent and actual conflict of interest that exists between our Readers’ interests and our interests because we: (i) receive the Shares as compensation for disseminating the Information and thereafter sell those Shares at any time for monetary gain, including a t the same time the Information is being disseminated or shortly thereafter or at any time; and (ii) buy and sells the Profiled Company’s shares in the open market at the same time or before the Information is being disseminated or shortly after the dissemination of the Information or at any time. Our gains from sale of the Shares may be substantial. | | | | | | | | | This message was sent to to ignoble.experiment@arconati.us by The Bull Exchange The Bull Exchange8 Cothall #458 Roseau Valley, 00152 | | Unsubscribe | Newsletter settings | Forward to a friend | ![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_t0j0JfdJjUmXRcafuSPGks3CHx4qPqAkkEqQphvN0NwA6YDRMjokDGxBG5kqGmEYhTzsoVPY6ts10CtXHqO45NZRipmRvGv4K_2iJNevrRpvjV1T4ybJrdhFfWf4uuVxcFx7XzsIpStM_1ZdgmixutSw=s0-d) | |
No comments:
Post a Comment
Keep a civil tongue.